Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease and Mortality in Individuals With Type 2 Diabetes.

Nordin M J HanssenJan WesterinkJean L J M ScheijenYolanda van der GraafCoen D A StehouwerMiranda T Schramnull null

Published in: Diabetes care (2018)

Plasma MGO and GO levels are associated with cardiovascular mortality in individuals with type 2 diabetes. Influencing dicaronyl levels may therefore be a target to reduce CVD in type 2 diabetes.

Keyphrases

cardiovascular disease
type diabetes
cardiovascular events
risk factors